Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatostatin effect in postprandial hypoglycemia.

L Baschieri1, A Antonelli, P del Guerra

  • 1Cattedra di Clinica Medica II, University of Pisa, Italy.

Metabolism: Clinical and Experimental
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Italian landscape of robotic-assisted kidney transplantation: results from a national survey.

Updates in surgery·2026
Same author

Search for Leptonic Decays of Dark Photons at NA62.

Physical review letters·2024
Same author

Safeguard stewards of biodiversity knowledge-Response.

Science (New York, N.Y.)·2024
Same author

The global distribution of plants used by humans.

Science (New York, N.Y.)·2024
Same author

Effects of saline nebulization on SARS-CoV-2 RNA spreading and exhaled bio-aerosol particles in COVID-19 patients.

The Journal of hospital infection·2023
Same author

Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study.

Journal of endocrinological investigation·2023

Somatostatin administration effectively prevented glucose-induced hypoglycemia in patients by suppressing excessive insulin release. This suggests potential therapeutic benefits of somatostatin analogues for severe idiopathic postprandial hypoglycemia.

Area of Science:

  • Endocrinology
  • Metabolic Disorders

Background:

  • Idiopathic postprandial hypoglycemia is characterized by excessive insulin secretion after glucose intake.
  • This condition leads to dangerous drops in blood glucose levels.

Purpose of the Study:

  • To investigate the effect of somatostatin on glucose, insulin, C-peptide, and glucagon levels in patients with idiopathic postprandial hypoglycemia.
  • To assess somatostatin's potential to prevent hypoglycemia.

Main Methods:

  • Seven patients with idiopathic postprandial hypoglycemia were studied.
  • Oral glucose was administered with or without intravenous somatostatin infusion.
  • Blood glucose, insulin, C-peptide, and glucagon levels were monitored.

Main Results:

Related Experiment Videos

  • Oral glucose alone caused excessive insulin release and hypoglycemia.
  • Somatostatin infusion significantly reduced insulin response and slowed glucose rise, preventing hypoglycemia.
  • Minor glucagon variations were observed; a rebound occurred post-infusion.

Conclusions:

  • Somatostatin effectively suppresses glucose-induced hypoglycemia in patients with idiopathic postprandial hypoglycemia.
  • Long-acting somatostatin analogues may be a viable therapeutic option for severe cases.